Xiaofeng Liao
About Xiaofeng Liao
Xiaofeng Liao is a Postdoctoral Associate at Yale University, specializing in CRISPR screening and non-canonical WNT pathways in T cells for tumor immunotherapy. He has extensive experience in immunology, having previously worked at Virginia Tech and the University of Science and Technology of China.
Current Role at Yale University
Xiaofeng Liao serves as a Postdoctoral Associate at Yale University, a position he has held since 2019. In this role, he conducts CRISPR screening and investigates non-canonical WNT pathways in T cells, focusing on applications in tumor immunotherapy. His research aims to enhance the understanding of immune responses in cancer treatment, contributing to advancements in immunotherapy strategies.
Previous Experience at Virginia Tech
Prior to his current position, Xiaofeng Liao worked at Virginia Tech for a total of six years. He began as a Graduate Research Assistant from 2012 to 2017, where he gained foundational experience in immunology. He later served as a Postdoctoral Scholar from 2018 to 2019, further developing his expertise in immune cell research and methodologies.
Educational Background in Immunology
Xiaofeng Liao earned his Doctor of Philosophy (Ph.D.) in Immunology from Virginia Tech, completing his studies from 2012 to 2017. His academic journey began at the University of Science and Technology of China, where he obtained a Bachelor’s Degree in Life Sciences from 2007 to 2011. This educational background provided him with a solid foundation in biological sciences and research methodologies.
Research Experience and Skills
Xiaofeng Liao possesses extensive hands-on experience with various immune cells, including T cells, NK cells, dendritic cells, and monocytes/macrophages. His expertise includes in vivo anti-tumor models and a range of immunoassay techniques. He specializes in CRISPR-based genome editing, particularly for T cell engineering, which is essential for his research in tumor immunotherapy.
Internship at Amgen
In 2016, Xiaofeng Liao completed a graduate internship at Amgen, located in South San Francisco, California. This two-month internship provided him with industry experience and exposure to biopharmaceutical research, complementing his academic and research endeavors.